首页> 外国专利> Hypolipaemic 5-substd. furan- and thiophene-2-carboxylic acid derivs. - prepd. e.g. by reacting phenol or thiophenol cpds. with 5-halomethyl-furan- or -thiophene-2-carboxylic acid cpds.

Hypolipaemic 5-substd. furan- and thiophene-2-carboxylic acid derivs. - prepd. e.g. by reacting phenol or thiophenol cpds. with 5-halomethyl-furan- or -thiophene-2-carboxylic acid cpds.

机译:降血脂5减。呋喃和噻吩-2-羧酸的衍生物。 -准备例如通过使苯酚或硫代苯酚cpds反应。用5-卤甲基-呋喃-或噻吩-2-羧酸的cpds。

摘要

New furan- and thiophene-2-carboxylic acid derivs. are of formula (I): (where R' is halogen, CF3, alkyl, aralkyl, aryl, alkoxy, aralkoxy, aryloxy, alkylthio, arylthio, alkylsulphinyl, arylsulphinyl alkylsulphonyl, arylsulphonyl, alkylcarbonyl, arylcarbonyl or alkyloxycarbonyl, the alkyl groups being 1-6C, and the aryl residues opt. being substd. in the 2-,3- or 4-position by lower alkyl, lower alkoxy, lower alkylthio or halogen; R2 and R3 are H or R'; or R' + R2 is methylenedioxy; R4 and R5 are H or lower alkyl; R6 is H, lower alkyl or halogen; R7 is H, lower alkyl or alkali metal; and X and Z are O or S). (I) are hypolipaemic agents which reduce blood levels of low density lipoproteins (LPL) and very low density lipoproteins (VLPL) but only slightly lower (or even increase) blood levels of high density lipoproteins (HDL). They can thus be used in the treatment and propylaxis of atherosclerosis. Relative liever weight changes after administration of (I) are absent or only slight.
机译:新的呋喃和噻吩-2-羧酸衍生物。具有式(I)的化合物:(其中R'为卤素,CF 3,烷基,芳烷基,芳基,烷氧基,芳烷氧基,芳氧基,烷硫基,芳硫基,烷基亚磺酰基,芳基亚磺酰基烷基磺酰基,芳基磺酰基,烷基羰基,芳基羰基或烷氧基羰基,烷基为1 -6C,且芳基残基优选在2-,3-或4-位上被低级烷基,低级烷氧基,低级烷硫基或卤素取代; R2和R3为H或R';或R'+ R2为亚甲基二氧基; R 4和R 5为H或低级烷基; R 6为H,低级烷基或卤素; R 7为H,低级烷基或碱金属; X和Z为O或S)。 (I)是降血脂药,可降低血液中低密度脂蛋白(LPL)和极低密度脂蛋白(VLPL)的水平,但仅略微降低(甚至增加)高密度脂蛋白(HDL)的血液水平。因此,它们可用于治疗和控制动脉粥样硬化。施用(I)后相对的体重没有变化或仅有轻微变化。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号